2'-O-(2-Methoxyethyl)guanosine is a chemically modified nucleoside. It is a derivative of guanosine where a 2-methoxyethyl group is attached to the 2'-oxygen atom of the ribose sugar moiety. This specific modification is a key structural feature designed to enhance the properties of oligonucleotides. This compound serves as a critical building block (phosphoramidite monomer) in the solid-phase synthesis of antisense oligonucleotides. The 2'-O-(2-methoxyethyl) (2'-MOE) modification is a widely used and well-established strategy to increase the binding affinity (melting temperature, Tm) of oligonucleotides to their complementary RNA targets, improve nuclease resistance, and enhance pharmacokinetic properties. It is a fundamental component in the development of therapeutic oligonucleotides, such as those used in the drugs Mipomersen (Kynamro) and Inotersen (Tegsedi). As a high-purity synthetic intermediate, it is specifically tailored for pharmaceutical research and development rather than as a general-purpose chemical reagent. Its primary value lies in its application in constructing next-generation nucleic acid therapeutics.